help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gora, J.
Right arrow Articles by Colrain, I. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gora, J.
Right arrow Articles by Colrain, I. M.
American Journal of Respiratory and Critical Care Medicine Vol 166. pp. 1225-1234, (2002)
© 2002 American Thoracic Society


Original Article

Evidence of a Sleep-Specific Blunted Cortical Response to Inspiratory Occlusions in Mild Obstructive Sleep Apnea Syndrome

John Gora, John Trinder, Robert Pierce and Ian M. Colrain

Department of Psychology, University of Melbourne; Austin and Repatriation Medical Centre, West Heidelberg, Victoria, Australia; Human Sleep Research Program, SRI International, Menlo Park, California

Correspondence and requests for reprints should be addressed to Dr. Ian M. Colrain, SRI International, 333 Ravenswood Avenue, Menlo Park, CA 94025. E-mail: ian.colrain{at}sri.com


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Obstructive sleep apnea syndrome (OSAS) patients have elevated non–rapid eye movement (REM) sleep arousal thresholds to inspiratory loading. To test the hypothesis that this is due to sleep-specific dampening of cortical responses to inspiratory effort, respiratory-related evoked potentials (RREPs) were evaluated in six mild OSAS patients and six age- and body mass index–matched controls during wakefulness and Stage 2 non-REM sleep. Electroencephalogram was recorded from six scalp sites (Fz, FCz, Cz, CPz, Pz, and O2). Electrooculogram, electromyogram, and mask pressure signals were also recorded. During sleep, pharyngeal pressure was recorded using a Millar pressure catheter placed 2 cm below the glottis. The RREP waveform was broadly similar in the two groups during wakefulness, but was markedly different during Stage 2 non-REM sleep. During wakefulness, only the N1 component showed reduced amplitude in the OSAS group. During sleep, the occlusion stimulus elicited fewer K-complexes in the OSAS patients. In addition, the N550 component in the average of K-complex responses was smaller in amplitude in the OSAS group. The data suggest that patients with mild OSAS have a "blunted" response to the respiratory occlusion stimulus. This appears not to be related to compromised mechanoreceptor function, as the RREP was normal in the patients when they were awake.

Key Words: apnea • sleep • respiratory-related evoked potential • K-complex • P300


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The presence of obstructive apneas during sleep can lead to excessive daytime sleepiness caused by persistent arousals after obstructive events. The consequent pathology is referred to as obstructive sleep apnea syndrome (OSAS). The cause of these arousals is the increased mechanical effort required to breathe against an obstructed or flow-limited airway (1). This effort can be measured directly by muscle electromyogram (EMG) activity (2) or indirectly via an increase in negative intrathoracic pressure (3, 4). OSAS patients have been shown to have a higher arousal threshold when compared with controls, requiring both a greater effort and larger negative intrathoracic pressure to produce an awakening (1). There are several possible explanations for this higher arousal threshold (1). First, OSAS patients may have damaged pressure detection mechanisms. Second, these patients may experience habituation to the repeated stimulation of pressure detectors with multiple apneic events. Third, OSAS patients may have a raised response threshold during sleep. This latter possibility could be due to an intrinsic property of the nervous system of OSAS patients, predisposing them to the disease. Alternatively, it may be because of an adaptation to assist them to maintain longer periods of uninterrupted sleep, such as might occur as a consequence of the sleep disturbance that is characteristic of OSAS.

It is possible to assess the cortical response to elevated inspiratory effort using the respiratory-related evoked potential (RREP) protocol, the RREP being the averaged cortical response to repeated presentation of a respiratory stimulus. A number of studies have investigated the RREP in normal awake subjects. The pattern of electroencephalogram (EEG) response includes a short-latency positive component, P1 (510), which is maximal over parietal scalp regions (1116) and is produced by bilateral activation of primary somatosensory cortex (17). There is also a short-latency negative component, Nf. This is maximal over frontal scalp sites (1116) and is produced by bilateral activation of the supplementary motor area (17). Late components include an N1 and P300 (7, 1215, 1823). These are thought to relate to attention and higher cognitive processing of stimuli.

During non–rapid eye movement (REM) sleep, the early RREP components are maintained, whereas the N1 is diminished and the P300 is not normally elicited (12, 21). However, two large-amplitude negative waves, peaking at approximately 350 and 550 ms, are elicited in sleep (N350 and N550, respectively) (12). The loss of the P300 and the occurrence of the N350 occur with the onset of theta activity during Stage 1 sleep (21). Furthermore, the N350 component persists into Stage 2 sleep where it is largely produced by averaging Vertex Sharp Waves in the individual stimulus responses (24, 25). The Stage 2 and slow wave sleep RREP are dominated, however, by another later and larger negative component, the N550 (12, 21, 2426). This is produced by including K-complexes in the average of responses to individual stimuli (26). K-complexes are large (up to 200 µV) biphasic waveforms that are readily observable in the ongoing EEG.

Only one study has investigated the RREP in apneic patients—and then only during wakefulness. Harver and colleagues (27) found that in response to midinspiratory occlusions applied during wakefulness, the P300 component was smaller in patients with apnea compared with controls; however, as this study was published in only abstract form, no information was given regarding detailed methodology, apnea severity, or RREP descriptive statistics. As such, no comprehensive RREP study has been performed on patients diagnosed with OSAS during wakefulness. In addition, no evoked potential studies have been performed on OSAS patients during sleep.

The most likely stimulus for the RREP is the mechanoreceptor response to the increase in inspiratory force that is generated by the increased inspiratory effort associated with application of the occlusion stimulus (2831). As indicated previously here, the increase in respiratory effort observed during apneic events in OSAS patients is also the most likely stimulus for the repeated arousals seen in these patients during sleep (1). Thus, the pattern of EEG response seen in the RREP should provide a window into the underlying nature of the effort/arousal relationship in apnea.

The aim of this study was to test the three hypotheses identified previously here, as to the elevated arousal threshold observed in OSAS patients. The research strategy was to compare the RREP response with midinspiratory occlusion stimuli presented during periods of both wakefulness and Stage 2 non-REM sleep in a group of patients diagnosed with mild OSAS and a group of age- and body mass index (BMI)-matched control subjects. The three hypotheses were as follows: (1) OSAS patients have impaired upper airway mechanoreceptor function. This hypothesis predicts that OSAS patients would have abnormal or absent RREP components during both wakefulness and non-REM sleep compared with control subjects. (2) OSAS patients habituate their response to increased effort as a consequence of repeated stimulation. This hypothesis predicts that OSAS patients (and possibly control subjects) would display a reduction in RREP component amplitudes at the end of the recording session when compared with the beginning. (3) OSAS patients have a sleep-specific increase in response threshold. This hypothesis predicts that OSAS patients would have a smaller sleep RREP response when compared with control subjects, but not differ in the wakefulness response.


    METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Subjects and Design
A total of nine patients diagnosed with mild OSAS (respiratory disturbance index [RDI] of between 5 and 15 events per hour) and eight age- and BMI-matched control subjects were tested in the study. Three of the OSAS patients and two of the control subjects experienced difficulty falling asleep while wearing the respiratory apparatus and electrocaps. As such, only the results from six OSAS patients (mean age, 38.83 ± 4.75; mean BMI, 26.87 ± 2.93; and mean RDI, 9.62 ± 3.65) and six age- and BMI-matched control subjects (mean age, 36.83 ± 4.49; mean BMI, 24.45 ± 1.98) are presented. Epworth Sleepiness Scale data and Multiple Wakefulness Data were collected from the OSAS patients. The Epworth Sleepiness Scale scores ranged from 8–17 (mean, 10.6 ± 3.8). The Multiple Wakefulness Data scores ranged from 14.38 to 40 minutes (mean, 31.48 ± 10.5).

OSAS patients were recruited from the Sleep Disorders Clinic of the Austin and Repatriation Medical Centre. As the study involved the application of short respiratory interruptions, it was necessary to recruit patients who despite their OSAS diagnosis, also demonstrated periods of unobstructed breathing during sleep. As such, only patients diagnosed with mild OSAS were used in the study. Patients were tested after their initial diagnostic study at the Austin and Repatriation Medical Centre, but before any continuous positive airway pressure intervention for OSAS. This was possible because of an approximate 6- to 8-week delay between diagnosis and implementation of continuous positive airway pressure. The control group was recruited from the university and Austin and Repatriation Medical Centre staff populations and was screened for possible sleep and respiratory problems. Specifically, they reported an absence of snoring and low levels of daytime sleepiness, as well as being screened for other respiratory pathology.

Subjects were studied for one night in the sleep laboratory at the University of Melbourne. Midinspiratory occlusions of a 1-second duration were applied during periods of both wakefulness and stable Stage 2 non-REM sleep. Individual trials were then subjected to evoked potential averaging, and the RREP response was determined. The University of Melbourne's Human Ethics Committee approved the study, and subjects gave written informed consent before participation.

Procedures
General laboratory procedures.
Subjects were asked to refrain from consuming caffeine or alcohol on the day before each sleep session and were required to maintain a supine position during data collection.

Application of respiratory stimuli.
Subjects wore a Hans Rudolph facemask (Series 7940; Hans Rudolph, Kansas City, MO) that was positioned so that the patients could comfortably respire with minimal facial muscle activity. The mask was secured using a head strap and was attached to a two-way nonrebreathing valve (Hans Rudolph Series 2600). The mask and breathing valve had a dead space of approximately 120 ml. Inspiratory airflow was measured using a heated Morgan pneumotachograph placed in the inspiratory line and connected to a differential pressure transducer (DP45—14; Validyne, Northridge, CA), with the output converted to a voltage signal using a carrier demodulator (Validyne CD15). The inspiratory port of the nonrebreathing valve was connected to a two-way stopcock that allowed either breathing of normal room air or the application of an occlusion. During both wakefulness and Stage 2 non-REM sleep, inspiration was interrupted by turning the stopcock to the occlusion setting during the early part of inspiration, as determined from the flow signal.

During the sleep session, two additional measures were added. First, a silicone rubber seal (Hans Rudolph Ultimate Seal) was placed between the mask and the face of the subject to eliminate the possibility of a mask leak. Second, pharyngeal pressure was also monitored (in addition to mask pressure) from a second port on the breathing mask using a Millar catheter (MPC-500). After recording the wakefulness data, the Millar catheter was inserted via one of the nares and positioned approximately 2 cm below the level of the glottis. Pharyngeal recording was conducted in five of the OSAS patients and five of the control subjects. Pharyngeal pressure was not recorded in one OSAS patient and one control subject because of difficulties associated with their ability to tolerate the Millar catheter.

Measurement of EEG, sleep state, and digital recording.
EEG activity was recorded from six gold cup surface electrodes (Fz, FCz, Cz, CPz, Pz, and O2) referenced to linked ears. The sites were primarily limited to central locations, as previous work has not indicated lateralization of RREP components (1217). Electrode impedances were tested and maintained below 5 K{Omega}. Electrooculogram (EOG) activity was recorded from electrodes placed slightly above or below the outer canthus of each eye. EMG activity was also recorded from electrodes placed over the submentalis muscle.

All EEG sites, the pneumotachograph airflow signal, and mask and pharyngeal pressure signals were continuously recorded on a Neuroscan system at a sampling rate of 1,000 Hz. The Cz and Fz EEG, EOG, EMG, and airflow signals were also recorded on a Compumedics system at a sampling rate of 500 Hz. The latter signals were used to determine sleep state using standard criteria (32).

Identification of occlusion trials.
Occlusion trials were identified in the continuous Neuroscan files using the airflow signal. This signal was chosen because it allowed the onset of the occlusion stimulus to be clearly determined. This signal corresponded closely to changes in both the mask and pharyngeal pressure signals; however, to display particular waveforms, different time periods before and after the occlusion stimulus (epochs) were used. The epoch length for the wakefulness pressure response (mask) was 500 ms before and 2,000 ms after the beginning of the midinspiratory occlusion. The epochs for the sleep pressure responses (mask and pharyngeal) were 1,000 ms before and 2,000 ms after the beginning of the occlusion. The epoch for the wakefulness RREP response was 100 ms before and 1,000 ms after the occlusion stimulus. Finally, the epoch length for the sleep RREP response was 100 ms before and 1,200 ms after the occlusion stimulus.

During wakefulness, individual trials were excluded from the analysis if they were affected either by body movements or eye blink artifact. In addition, during sleep, individual trials were excluded from the analysis if they demonstrated an arousal response according to ASDA criteria (33).

RREP component definitions.
The early-latency RREP component definitions used during wakefulness in this study were an Nf-negative component appearing between 40–80 ms after stimulus and a P1-positive component appearing between 80–130 ms after stimulus. Although there has been some variability in the naming of positive components in response to respiratory stimuli in the region of 100 ms, the present designation has been used to be consistent with previous publications from this laboratory (1215, 17, 21). The late RREP component definitions used during wakefulness were an N1-negative component appearing between 100–200 ms after stimulus, a P2-positive component appearing between 200–300 ms after stimulus, and a P300-positive component appearing between 300–400 ms after stimulus. As the N2 could not be clearly detected in the majority of subjects, this component was not analyzed. These latencies are longer than those reported in previous research (1215, 17, 21), an explanation for which has been presented in the DISCUSSION.

The only sleep RREP component analyzed in this study was the N550. This component was defined as the late-latency–negative component that appeared between 500–800 ms in response to the occlusion stimulus. As the N550 is comprised of a high-amplitude phasic event, the K-complex (12, 21, 2426), the sleep data were averaged both over all trials (irrespective of the occurrence of a visually identified K-complex) and over trials that contained a visually identified K-complex.

The rationale and methods for these procedures have been described in detail in a previous publication (25). Briefly, K-complexes were visually identified in the raw EEG using Rechtschaffen and Kales' criteria: "A waveform having a well delineated negative sharp wave which is immediately followed by a positive component. The total duration of the complex should exceed 0.5 sec" (32). An amplitude criterion was also implemented in that the negative wave had to have an amplitude of at least 75 µV (34, 35) at the Fz electrode site. The N350, which is based on the vertex sharp wave (24, 25), was not analyzed, as the stimulus elicited too few vertex sharp waves in the patient group.

Statistical Analyses
Peak mask pressure was compared between the two groups during wakefulness and sleep using a 2 x 2 analysis of variance (ANOVA) with repeated measures on the wake–sleep factor. Furthermore, within sleep, the two groups (OSAS patients and control subjects) were compared with respect to pressures generated in the pharynx and mask during the occlusion using a two-groups by two-pressure measurements ANOVA with repeated measures on the second factor.

During wakefulness, the amplitude and latency of the Nf, P1, N1, P2, and P300 components between the OSAS and control groups were compared using a series of two-groups by six-sites (Fz, FCz, Cz, CPz, Pz, O2) ANOVAs with repeated measures on the second factor. In addition, a series of independent sample t tests was conducted at the scalp site, where each component was maximal in amplitude.

During sleep, the probability of a K-complex being elicited by the occlusion stimulus in the two groups was investigated using an independent-samples t test. The amplitude of the N550 component was assessed by a two-groups by six-sites ANOVA and by a t test at Fz, where the amplitude of this component was maximal. As noted previously here, this analysis was conducted first on all trials, irrespective of whether a K-complex occurred, and second on only those trials on which a K-complex occurred. In the latter analysis, the RREP for K-complex trials was also compared with trials on which neither a K-complex nor a vertex sharp wave occurred.

A final analysis investigated whether either the frequency of K-complex elicitation or the amplitude of the N550 component for K-complex trials habituated over the duration of the study session. To achieve this, the total number of trials performed on each subjects' study night were divided into four equal quartiles. A 2 (group) x 4 (quartile) ANOVA was conducted on the data from the Fz site, for both the number of K-complexes elicited and on N550 amplitude in the all K-complex phasic response condition.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Intrathoracic Pressure Responses
Figures 1 and 2A illustrate the grand average waveform of the mask pressure signal for the average of all occlusion trials in both the OSAS and control groups during wakefulness and sleep, respectively. They illustrate that the negative mask pressure generated in response to the midinspiratory occlusion stimulus was essentially identical in the two groups during wakefulness (-3.6 ± 1.2 and -3.6 ± 0.6 cm H2O for OSAS and control subjects, respectively) but smaller (less negative) during sleep in the patients (-2.2 ± 0.3 and -4.4 ± 1.3 cm H2O, respectively). The interaction effect, F(1, 10) = 11.43, p < 0.01, and main effect of groups, F(1, 10) = 5.90, p < 0.05, were significant, but not the effect of sleep–wake state, F(1, 10) = 0.97, p > 0.05. Thus, OSAS patients had a smaller (less negative) mask pressure during sleep, but not during wakefulness.



View larger version (20K):
[in this window]
[in a new window]
 
Figure 1. Average mask pressure waveform during wakefulness in response to the midinspiratory occlusion stimulus for the OSAS and control groups.

 



View larger version (38K):
[in this window]
[in a new window]
 
Figure 2. Average mask (A) and pharyngeal (B) waveforms during Stage 2 non-REM sleep in response to the midinspiratory occlusion stimulus for the OSAS and control groups.

 
Figure 2 illustrates the grand average waveform for the mask (Figure 2A) and pharyngeal (Figure 2B) pressure signals for the average of all midinspiratory occlusion trials in the OSAS and control groups during sleep. Pharyngeal pressure was larger (more negative) in the OSAS patients (-5.4 ± 1.2 cm H2O) compared with control subjects (-4.4 ± 1.2 cm H2O). In contrast, as noted in the previously mentioned analysis, Figure 2A indicates that the OSAS patients had smaller (less negative) mask pressure values than subjects in the control group. A two-factor ANOVA, with repeated measures on the wake–sleep factor, revealed that there was a significant main effect of pressure type for intrathoracic pressure amplitude, F(1, 4) = 97, p < 0.001. This indicated that the pressure generated in response to the occlusion stimulus was larger (more negative) when measured at the epiglottis than when measured at the mask. There was not a significant difference between the groups, F(1, 4) = 0.43, p > 0.05. However, a significant pressure type by group interaction, F(1, 4) = 8.16, p < 0.05, indicated that the pharyngeal-to-mask pressure difference was significantly greater in the OSAS group than control group.

RREP Responses
Wakefulness.
The average number of artifact-free midinspiratory occlusion trials presented to each subject during wakefulness was 115 ± 8 in the OSAS group and 110 ± 10 in the control group.

Early-latency components.
Mean amplitude and latency values, F ratios, and significance levels for the Nf and P1 components for each group over the six sites are presented in Table 1 . Figure 3 depicts the average RREP waveforms during wakefulness for the groups at the Fz (Figure 3A), Cz (Figure 3B), and Pz (Figure 3C) scalp sites. The amplitude of these components did not differ as a function of group or between groups over sites. Furthermore, independent sample t tests conducted at the maximal sites for each component were not significant (t[1,10] = 0.16, p > 0.05 for Nf at Fz and t[1,10] = -0.117, p > 0.05 for P1 at Pz). It should be noted that the sites of the maximal components were consistent with previous RREP research (1217). The latency of the components did show significant interaction effects, although latency was not significant at the maximum sites (t[1,10] = -1.39, p > 0.05 for Nf at Fz and t[1,10] = 0.48, p > 0.05 for P1 at Pz) and the latency pattern was not systematic over sites (see Table 1).


View this table:
[in this window]
[in a new window]
 
TABLE 1. Mean amplitude and latency values for the nf and P1 components for the osas and control groups in response to the midinspiratory occlusion stimulus

 




View larger version (67K):
[in this window]
[in a new window]
 
Figure 3. Average RREP waveforms during wakefulness for both the OSAS and control groups at the Fz (A), Cz (B), and Pz (C) scalp sites, respectively.

 
Late-latency components.
Values for the late-latency components are presented in Table 2 and Figure 3. An ANOVA between groups and over sites did not reveal any significant group or group by site interaction effects for the amplitude of the N1, P2, or P300 components; however, the N1 component was significantly smaller in the OSAS patients at the maximal N1 site, Cz, as indicated by an independent groups t test, t(1, 10) = 2.35, p < 0.05; however, neither P2, t(1, 10) = -0.40, p > 0.05, nor P300, t(1, 10) = -1.14, p > 0.05, were significantly different at their maximum sites of Cz and Pz, respectively. Furthermore, a latency difference was not observed between the two groups for N1, t(1, 10) = -0.65, p > 0.05; P2, t(1, 10) = -0.61, p > 0.05; or P300, t(1, 10) = 0.44, p > 0.05 (see Figure 3). Again, components were maximal at sites anticipated on the basis of previous research (1315, 18, 21).


View this table:
[in this window]
[in a new window]
 
TABLE 2. Mean amplitude and latency values for the N1, P2, and P300 components for the osas and control groups in response to the onset of the occlusion stimulus

 
Stage 2 sleep.
The average number of midinspiratory occlusion trials presented to each group during Stage 2 sleep was 223 ± 13 in the OSAS group and 222 ± 17 in the control group. The percentage of occlusion trials that produced an arousal was significantly greater in the control group (9.38 ± 1.99%) compared with the OSAS group (4.74 ± 2.29%), t(10) = 3.65, p < 0.01.

Late-latency components: all-trial average.
Figure 4 depicts the average Stage 2 sleep waveform for all trials at each recorded scalp site for both the OSAS and control groups (Table 3) . Visual inspection of Figure 4 illustrates that the N550 component was larger in the control group compared with OSAS group at each scalp site, with a significant group effect. Figure 4 also revealed that, consistent with the literature, the N550 was largest frontally (at the Fz scalp site) and became progressively smaller in amplitude with a shift from anterior to posterior scalp sites, both the main effect of site and the interaction effect being significant.



View larger version (28K):
[in this window]
[in a new window]
 
Figure 4. Average RREP waveforms during Stage 2 non-REM sleep (all-trial average) for the OSAS and control groups at each recorded scalp site.

 

View this table:
[in this window]
[in a new window]
 
TABLE 3. Mean amplitude and latency values for the N550 component for k-complex trials for the obstructive sleep apnea syndrome and control groups

 
As noted previously here, the RREP N550 component is related to K-complex elicitation (2426). Therefore, the smaller amplitude N550 in the OSAS group in the all-trial average in this study may be due to either a reduction in the number of trials in which K-complexes were elicited or to differences in the amplitude of elicited K complexes. The probability of the stimulus eliciting a K-complex was indeed lower in the OSAS group (0.06 ± 0.02 and 0.18 ± 0.04 for the OSAS and control groups, respectively, t[1, 10] = -7.4, p < 0.01); however, the amplitude of K-complexes was also smaller. Figure 5 illustrates the Fz Stage 2 RREP, for trials on which a K-complex occurred and trials on which neither a K-complex nor a vertex sharp wave was observed. Figure 5 (Table 3) reveals that the N550 was smaller in the OSAS group compared with control group. Statistically, there were significant group, site, and group-by-site effects. Furthermore, an independent samples t test revealed that this difference was significant at the maximal site, Fz, t(1, 10) = 2.7, p < 0.05. Although Figure 5 illustrates that the N550 component appeared slightly later in the OSAS compared with control group, this difference was not significant, t(1, 10) = 0.85, p < 0.05. Finally, Figure 5 also reveals that the waveform for trials on which no phasic event occurred had no discernible components present in either group.



View larger version (23K):
[in this window]
[in a new window]
 
Figure 5. Average Fz RREP waveforms during Stage 2 non-REM sleep for K-complex and nonphasic event trials for the OSAS and control groups.

 
Finally, an analysis was performed to investigate any possible habituation in either K-complex elicitation or N550 amplitude (for trials on which a K-complex occurred) across the data collection session for each subject. The number of K-complexes and the amplitude of the N550 component in each of the four quartiles are represented graphically in Figures 6A and 6B , respectively. Figure 6 revealed that for each quartile, the occlusion stimulus elicited more K-complexes and a larger amplitude N550 component in the control subjects. This was confirmed by a significant main effect of group, for K-complex frequency, F(1, 10) = 77.1, p < 0.001, and N550 amplitude, F(1, 10) = 5.09, p < 0.05. There was no main effect of quartile for K-complex elicitation frequency, F(3, 30) = 2.15, p > 0.05, or N550 amplitude F(3, 30) = 1.87, p > 0.05. There was no group by quartile interaction for either variable.



View larger version (30K):
[in this window]
[in a new window]
 
Figure 6. Within-night variation in K-complex elicitation frequency (A) and N550 amplitude (B) for K-complex trials for the OSAS group (shaded bars) and control groups (solid bars).

 

    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The data revealed that during wakefulness, a similar cortical response was observed to the midinspiratory occlusion stimulus in a group of patients diagnosed with mild obstructive sleep apnea and a group of age- and BMI-matched control subjects. Although there was a difference in N1 amplitude between the two groups, when assessed at the site of the maximal amplitude, no other amplitude or latency differences were observed for the remaining early- or late-latency wakefulness RREP components. In contrast, the cortical response during Stage 2 sleep was markedly different between the OSAS and control groups. OSAS patients demonstrated a smaller amplitude evoked response during sleep that appeared to be due to both a reduction in the number of elicited K-complexes and a reduction in the amplitude of K-complexes, as reflected in the N550 component of the average of trials that contained only K-complexes.

Wakefulness
The wakefulness mask pressure profiles indicate that both the OSAS and control groups demonstrated almost identical negative mask pressures in response to the midinspiratory occlusion stimulus. This suggests that during wakefulness the two groups had similar respiratory efforts and maintained similar airway patency in response to the stimulus.

The wakefulness early-latency RREP response, the Nf and P1 components, demonstrated similar amplitudes and latencies in the two groups. These components are believed to reflect cortical activation by the afferent signal (5), with Nf being produced bilaterally in the supplementary motor area and P1 bilaterally in primary somatosensory cortex (17). The evoked RREP is most likely due to stimulation of respiratory muscle afferents in the airway, lungs, and chest wall that occur in association with intrathoracic pressure changes in response to the occlusion stimulus. It is therefore likely that any impairment in mechanoreceptor function in the OSAS patients would translate to a deviation from the "normal" wakeful RREP response. The similarity of the evoked early-latency RREP between the OSAS patients and the control group in this study would therefore suggest that OSAS patients have relatively intact or unimpaired respiratory mechanoreceptor function. It would also suggest that their sleep-disordered breathing is not due to a problem associated with afferent transmission of respiratory information to the cortex.

It should be noted that the early-latency wakefulness RREP components reported in this study appeared approximately 20–40 ms later than those reported in previous research (1217). This relative delay was most likely due to the different methods used to apply the midinspiratory occlusion and resistive loads. Previous research presented stimuli using a gas-activated valve trigger that had a very rapid rise time. In contrast, the rise time of the occlusion using the hand held stopcock in this study was slower.

For the most part, the late-latency wakefulness RREP response was very similar in both the OSAS and control groups. The N1 component in the OSAS group was smaller than that of the control group, although only when compared specifically at its maximum site; however, P2 and P300 amplitude differences were not observed between the two groups. In addition, no N1, P2, or P300 latency differences were observed between the OSAS and control groups. These data further support the notion that OSAS patients have relatively intact or unimpaired respiratory mechanoreceptor function.

The N1, which was smaller in the OSAS compared with the control group, is influenced by both sensory input and cognitive factors (36); however, it is unlikely that the difference in N1 was due to a variation in sensory processing. This is because mask pressure did not vary between the groups during wakefulness and because the earlier short-latency RREP components that are affected by sensory factors were not different between the groups. In the cognitive domain, N1 is modulated by a variation in levels of attention and arousal (36). Gora and colleagues (21) reported that the RREP N1 decreased significantly after the onset of Stage 1 sleep. This was recently confirmed for the auditory N1 by Colrain and colleagues (37). In other studies of drowsiness (38), the auditory N1 was significantly reduced as soon as reaction times started to increase. Thus, the decrease in the amplitude of N1 might be due to greater fatigue or sleepiness in the patients. Consistent with this, the Multiple Wakefulness Data and Epworth Sleepiness Scale scores obtained from the patients were indicative of low to moderate levels of sleepiness. Although two patients failed to sleep in the Multiple Wakefulness Data (i.e., score of 40), others ranged down as far as 14 minutes, and the mean Epworth Sleepiness Scale was 10.6. The greater level of sleepiness is likely to be due to the sleep fragmentation commonly reported for OSAS patients. The data therefore raise the possibility that the N1 could be a sensitive index of daytime alertness in OSAS.

Interestingly, this study demonstrated no P300 amplitude or latency variation between the OSAS and control groups in response to the occlusion stimulus. The presence of a P300 is believed to reflect conscious "awareness" of a stimulus (39). P300 amplitude has been theorized to be contributed to by multiple neural generators, with the activity of each generator reflecting a discrete aspect of cognitive processing, such as stimulus probability, attention, equivocation, stimulus meaning, and stimulus value or relevance (40, 41). Indeed, the RREP P300 has been shown to vary systematically with several of these parameters (13, 14, 18).

These data are in contrast to the only other RREP study conducted on OSAS patients during wakefulness. Harver and colleagues (27) reported a smaller amplitude P300 in OSAS patients compared with age-matched control subjects; however, as this study was published only in abstract form, no details were given regarding detailed methods, apnea severity, or descriptive RREP statistics. This has made it difficult to draw any conclusions regarding the different results reported between the two studies. Studies conducted on OSAS patients employing other modalities have reported mixed results regarding P300 amplitude and latency to auditory and visual stimuli. There is consistency in studies of visual P300, with all studies showing no effect for amplitude, but OSAS patients having a delayed latency (4245); however, the consistency disappears in studies of the auditory P300. Two studies reported reduced auditory P300 amplitude in patients diagnosed with severe OSAS (46, 47); however, three studies by Sangal and Sangal found no difference between OSAS patients and control subjects (4345), this despite the same group reporting in another article that the only visual or auditory P300 measure to correlate significantly with RDI was auditory P300 amplitude (48). Three studies have reported an increased auditory P300 latency in OSAS (43, 46, 47), and two reported no difference (44, 45).

The strongest effect from the previously mentioned studies seems to be an increase in P300 latency with OSAS. Variations in P300 latency are believed to reflect differences in stimulus evaluation speed (49). The delayed P300 observed in severe OSAS patients in previous EP research has therefore been interpreted as suggesting some form of brain dysfunction relating to the processing speed of cognitive information (42, 45). The lack of any difference in P300 amplitude or latency between the mild OSAS patients and age- and BMI-matched controls in this study may be due to several factors. The first is that the patients in this study had relatively mild apnea. That is, it is likely that the sleep of patients with mild OSAS is not as fragmented as the sleep of patients diagnosed with severe OSAS. A second explanation is that the relatively young age of the OSAS group (average of 38 years) means that it is likely that they have not had apnea for a long period of time. Older subjects with a longer disease history may well experience the accumulative effects of hypoxemia and sleep fragmentation that could lead to diffuse damage, that in all probability would be reflected in ERP results. Such effects would likely be permanent. In this context it should be noted that treatment with CPAP did not decrease P300 latency significantly in two studies (42, 45). In another two, significant latency reductions occurred (46, 47), but posttreatment values were still substantially later than those seen in control subjects. Finally, the failure to find a difference may relate to the nature of the paradigm employed. Typically, the P300 is elicited using an oddball task in which subjects are asked to detect a rare target stimulus occurring among a train of more frequently occurring standard stimuli. In this study, a more biologically relevant stimulus (occlusion of breathing) was employed. It is possible that such a biologically relevant stimulus was automatically detected in the waking state for both patients and controls. Thus, even though there was evidence of sleepiness in the patients, they may still have been able to detect the occlusion of inspiration.

Stage 2 Sleep
The arousal threshold to inspiratory loading has been reported to be higher in OSAS patients relative to control subjects (1). These data are supportive of this finding, in that the control subjects had a significantly greater number of arousals to occlusion stimuli than the OSAS patients. This result would indicate that despite their young age and mild apnea, the OSAS groups were displaying increased sleep pressure as a response to the fragmenting effects of the apneas that they experienced.

Berry and Gleeson (1) have indicated that OSAS patients often display airway closure in response to externally applied occlusions. In this study, the midinspiratory occlusion stimulus produced a larger pharyngeal pressure response in OSAS than in control subjects. At the same time, the mask pressure response in OSAS patients was substantially less than that of the controls. These data indicate that during sleep, control subjects maintained a patent airway after external occlusion of the inspiratory line, but that OSAS patients experienced at least partial closure of the upper airway at some point between the epiglottis and the mouth. The intensity of the midinspiratory occlusion stimulus, as indicated by pharyngeal pressure, was thus greater for the OSAS patients.

The early-latency P1 and Nf components have been reported to be present during Stage 2 sleep in response to midinspiratory occlusions (12, 50); however, these components, as well as the N1 component, could not be reliably detected in the grand mean averages in this study. The most likely explanation for this is that an insufficient number of stimuli were averaged to overcome the lower signal to noise ratio between the components and the background EEG experienced during Stage 2 sleep. Webster and Colrain (12), for example, typically averaged over 300 trials per subject in Stage 2 sleep. Second, although the slower rise time of the midinspiratory occlusion stimulus used in this study elicited the wakeful early-latency components, this stimulus may not have been abrupt enough to reliably elicit sleep early-latency components. Both of these explanations imply that to elicit the early-latency components during Stage 2 sleep, a larger number of trials would have to be conducted. Alternatively, the use of a more abrupt stimulus, such as that used in earlier studies (12, 50), may also assist in more reliable elicitation of the early-latency components.

The data revealed that when all trials were included in the evoked potential average, the sleep RREP looked markedly different in the OSAS compared with control group. That is, the N550 in the OSAS group was much smaller in amplitude than the N550 in the control group. This was due to two factors. First, N550 is related to K-complex elicitation (21, 2426). Thus, the lower number of K-complexes elicited in response to the occlusion in the OSAS group reduced N550 amplitude. Second, there was a reduction in K-complex amplitude.

It seems unlikely that the difference in the elicitation of K-complexes was due to differences in the intensity of the occlusion stimulus, as the effective stimulus was larger (that is the intrathoracic pressure was more negative) in the OSAS group. The difference is also unlikely to be due to impaired mechanoreceptor function, as there were only minor differences in RREP components between the two groups during wakefulness. A more likely explanation may be that the OSAS group had a raised threshold to respiratory events during sleep. As pointed out by Berry and Gleeson (1), this raised threshold may be either intrinsic or due to the effects of sleep deprivation. The similar wakefulness profiles suggest that if the raised threshold to respiratory events is indeed intrinsic, its effects appear to be sleep specific.

The data also revealed that the amplitude of the K-complex was smaller in the OSAS compared with control group. That is, the N550 for trials on which a K-complex occurred was significantly reduced in the OSAS compared with control group. This would suggest that not only does there appear to be a threshold effect for elicitation frequency in the OSAS group, but there also appears to be cortical dampening when a K-complex is actually elicited.

The latency of the N550 observed in the study was relatively long (Table 3); however, the latency is consistent with previous studies using a respiratory occlusion stimulus. We believe this relates to the rise time of the stimulus (see Gora and colleagues for a discussion of this issue [21]).

Additional analyses were conducted to determine whether either the OSAS or control groups habituated to the occlusion stimulus over the duration of the study night. This analysis revealed that there was no change in K-complex elicitation frequency or N550 amplitude across the duration of the study night for either group. These data exclude the possibility that the smaller number of K-complexes in the OSAS group was due to these patients habituating to the occlusion stimulus over the duration of the sleep session; however, it remains possible that OSAS patients have habituated to occlusions over the course of their disease and that this is the basis of the differences in the N550 component identified in this study.

Conclusions
The data revealed that in response to a midinspiratory occlusion stimulus, the wakefulness RREP in patients diagnosed with mild OSAS was very similar to that of a group of age- and BMI-matched control subjects, with the exception of a reduction in N1 amplitude. In contrast, the N550 in the all-trial average sleep RREP was much reduced in the OSAS compared with the control group. This was found to be due to both a smaller proportion of K-complexes being elicited in the OSAS group and to smaller K-complex amplitude. This would suggest that in terms of cortical responsiveness, OSAS is not related to either impaired afferent transmission of respiratory information or impaired mechanoreceptor function but, rather, is a sleep-specific problem. Of course, a sleep effect on either of these mechanisms is not eliminated by these data. Thus, in general, these data support the view that the higher inspiratory effort required to cause an arousal in OSAS patients is due to either the prolonged effect of sleep deprivation or an intrinsic, sleep-specific increase in response threshold.

Received in original form June 1, 2001; accepted in final form August 6, 2002


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Berry RB, Gleeson K. Respiratory arousal from sleep: mechanisms and significance. Sleep 1997;20:654–675.[Medline]
  2. McEvoy RD, Popovic RM, Saunders NA, White DP. Ventilatory responses to sustained eucapnic hypoxia in healthy males during wakefulness and NREM sleep. Sleep 1997;20:1008–1011.[Medline]
  3. Black JE, Guilleminault C, Colrain IM, Carrillo O. Upper airway resistance syndrome: central electroencephalographic power and changes in breathing effort. Am J Respir Crit Care Med 2000;162:406–411.[Abstract/Free Full Text]
  4. Morrell MJ, Arabi Y, Zahn B, Badr MS. Progressive retropalatal narrowing preceding obstructive apnea. Am J Respir Crit Care Med 1998; 158:1974–1981.[Abstract/Free Full Text]
  5. Davenport PW, Friedman WA, Thompson FJ, Franzen O. Respiratory-related cortical potentials evoked by inspiratory occlusion in humans. J Appl Physiol 1986;60:1843–1848.[Abstract/Free Full Text]
  6. Revelette WR, Davenport PW. Effects of timing of inspiratory occlusion on cerebral evoked potentials in humans. J Appl Physiol 1990;68:282–288.[Abstract/Free Full Text]
  7. Strobel RJ, Daubenspeck JA. Early and late respiratory-related cortical potentials evoked by pressure pulse stimuli in humans. J Appl Physiol 1993;74:1484–1491.[Abstract/Free Full Text]
  8. Knafelc M, Davenport PW. Relationship between resistive loads and P1 peak of respiratory-related evoked potential. J Appl Physiol 1997;83: 918–926.[Abstract/Free Full Text]
  9. Knafelc M, Davenport PW. Relationship between magnitude estimation of resistive loads, inspiratory pressures, and the RREP P(1) peak. J Appl Physiol 1999;87:516–522.[Abstract/Free Full Text]
  10. Davenport PW, Cruz M, Stecenko AA, Kifle Y. Respiratory-related evoked potentials in children with life-threatening asthma. Am J Respir Crit Care Med 2000;161:1830–1835.[Abstract/Free Full Text]
  11. Hammond CS, Gaeta H, Sapienza C, Davenport PW. Respiratory-related evoked potential elicited by expiratory occlusion. J Appl Physiol 1999; 87:835–842.[Abstract/Free Full Text]
  12. Webster KE, Colrain IM. Multichannel EEG analysis of respiratory evoked-potential components during wakefulness and NREM sleep. J Appl Physiol 1998;85:1727–1735.[Abstract/Free Full Text]
  13. Webster KE, Colrain IM. The relationship between respiratory-related evoked potentials and the perception of inspiratory resistive loads. Psychophysiology 2000;37:831–841.[CrossRef][Medline]
  14. Webster KE, Colrain IM. The respiratory-related evoked potential: effects of attention and occlusion duration. Psychophysiology 2000;37: 310–318.[CrossRef][Medline]
  15. Webster K, Colrain IM. P3-specific amplitude reductions to respiratory and auditory stimuli in subjects with asthma. Am J Respir Crit Care Med 2002;166:47–52.[Abstract/Free Full Text]
  16. Davenport PW, Colrain IM, Hill PM. Scalp topography of the short-latency components of the respiratory-related evoked potential in children. J Appl Physiol 1996;80:1785–1791.[Abstract/Free Full Text]
  17. Logie ST, Colrain IM, Webster KE. Source dipole analysis of the early components of the RREP. Brain Topogr 1998;11:153–164.[CrossRef][Medline]
  18. Webster K, Adey S, Colrain IM. Stimulus probability and P3 in the respiratory-related evoked potential (RREP). Psychophysiology 2002;39: 9–15.[CrossRef][Medline]
  19. Bloch-Salisbury E, Harver A. Effects of detection and classification of resistive and elastic loads on endogenous event-related potentials. J Appl Physiol 1994;77:1246–1255.[Abstract/Free Full Text]
  20. Bloch-Salisbury E, Harver A, Squires NK. Event-related potentials to inspiratory flow-resistive loads in young adults: stimulus magnitude effects. Biol Psychol 1998;49:165–186.[CrossRef][Medline]
  21. Gora J, Colrain IM, Trinder J. Respiratory-related evoked potentials during the transition from alpha to theta EEG activity in stage 1 NREM sleep. J Sleep Res 1999;8:123–134.[CrossRef][Medline]
  22. Harver A, Squires NK, Bloch-Salisbury E, Katkin ES. Event-related potentials to airway occlusion in young and old subjects. Psychophysiology 1995;32:121–129.[Medline]
  23. Zhao W, Martin D, Davenport PW. The respiratory-related evoked potentials in response to inspiratory occlusions in double lung transplant recipients. J Appl Physiol 2002;93:1779–1785.[Abstract/Free Full Text]
  24. Gora J, Colrain I, Trinder J. Can the cortical response to mid-inspiratory occlusions provide a useful model of obstructive events in human subjects during stage 2 NREM sleep? Sleep 2001;24:81–89.[Medline]
  25. Colrain IM, Webster KE, Hirst G, Campbell KB. The roles of vertex sharp waves and K-complexes in the generation of N300 in auditory and respiratory-related evoked potentials during early stage 2 NREM sleep. Sleep 2000;23:97–106.[Medline]
  26. Colrain IM, Webster KE, Hirst G. The N550 component of the evoked K-complex: a modality non-specific response? J Sleep Res 1999;8:273–280.[CrossRef][Medline]
  27. Harver A, Bloch E, Sampson M, Carter D. Respiratory-related evoked potentials in patients with obstructive sleep apnea and age-matched controls [abstract]. FASEB J 1991;5:A735.
  28. Gandevia SC, Macefield G. Projection of low-threshold afferents from human intercostal muscles to the cerebral cortex. Respir Physiol 1989; 77:203–214.[CrossRef][Medline]
  29. Davenport PW, Thompson FJ, Reep RL, Freed AN. Projection of phrenic nerve afferents to the cat sensorimotor cortex. Brain Res 1985;328:150–153.[CrossRef][Medline]
  30. Davenport PW, Shannon R, Mercak A, Reep RL, Lindsey BG. Cerebral cortical evoked potentials elicited by cat intercostal muscle mechanoreceptors. J Appl Physiol 1993;74:799–804.[Abstract/Free Full Text]
  31. Davenport PW, Hutchison AA. Cerebral cortical respiratory-related evoked potentials elicited by inspiratory occlusion in lambs. J Appl Physiol 2002;93:31–36.[Abstract/Free Full Text]
  32. Rechtschaffen A, Kales A, editors. A manual of standardized terminology, techniques, and scoring system for sleep stages of human subjects. Los Angeles: UCLA Brain Information Service/Brain Research Institute; 1968.
  33. EEG arousals: scoring rules and examples: a preliminary report from the Sleep Disorders Atlas Task Force of the American Sleep Disorders Association. Sleep 1992;15:173–184.[Medline]
  34. Bastien C, Campbell K. The evoked K-complex: all-or-none phenomenon? Sleep 1992;15:236–245.[Medline]
  35. Bastien C, Campbell K. Effects of rate of tone-pip stimulation on the evoked K-complex. J Sleep Res 1994;3:65–72.[Medline]
  36. Naatanen R, Picton T. The N1 wave of the human electric and magnetic response to sound: a review and an analysis of the component structure. Psychophysiology 1987;24:375–425.[Medline]
  37. Colrain IM, DiParsia P, Gora J. The effects of sleep onset and stimulus relevance on auditory evoked responses. Can J Exp Psychol 2000;54: 243–254.[Medline]
  38. Harsh J, Voss U, Hull J, Schrepfer S, Badia P. ERP and behavioral changes during the wake/sleep transition. Psychophysiology 1994;31: 244–252.[Medline]
  39. Picton T. The P300 wave of the human event-related potential. J Clin Neurophysiol 1992;9:456–479.[Medline]
  40. Johnson R. A triarchic model of P300 amplitude. Psychophysiology 1986; 23:367–384.[Medline]
  41. Johnson R. On the neural generators of the P300 component of the event-related potential. Psychophysiology 1993;30:90–97.[Medline]
  42. Kotterba S, Rasche K, Widdig W, Duscha C, Blombach S, Schultze-Werninghaus G, Malin J. Neuropsychological investigations and event-related potentials in obstructive sleep apnea syndrome before and during CPAP-therapy. J Neurol Sci 1998;159:45–50.[CrossRef][Medline]
  43. Sangal R, Sangal J. P300 latency: abnormal in sleep apnea with somnolence and idiopathic hypersomnia, but normal in narcolepsy. Clin Electroencephalogr 1995;26:146–153.[Medline]
  44. Sangal R, Sangal J. Obstructive sleep apnea and abnormal P300 latency topography. Clin Electroencephalogr 1997;28:16–25.[Medline]
  45. Sangal R, Sangal J. Abnormal visual P300 latency in obstructive sleep apnea does not change acutely upon treatment with CPAP. Sleep 1997;20:702–704.[Medline]
  46. Rumbach L, Krieger J, Kurtz D. Auditory event-related potentials in obstructive sleep apnea: effects of treatment with nasal continuous positive airway pressure. Electroencephalogr Clin Neurophysiol 1991;8: 454–457.
  47. Walsleben J, Squires NK, Rothenberger VL. Auditory event-related potentials and brain dysfunction in sleep apnea. Electroencephalogr Clin Neurophysiol 1989;74:297–311.[CrossRef][Medline]
  48. Sangal R, Sangal J. Measurement of P300 and sleep characteristics in patients with hypersomnia: do P300 latencies, P300 amplitudes and multiple sleep latency and maintenance of wakefulness tests measure different factors? Clin Electroencephalogr 1997;28:179–184.[Medline]
  49. Magliero A, Bashore T, Coles M, Donchin E. On the dependence of P300 latency on stimulus evaluation processes. Psychophysiology 1984; 21:171–186.[Medline]
  50. Wheatley J, White D. Influence of NREM sleep on respiratory-related cortical evoked potentials in normal humans. J Appl Physiol 1993;74: 1803–1810.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Proc Am Thorac SocHome page
D. J. Eckert and A. Malhotra
Pathophysiology of Adult Obstructive Sleep Apnea
Proceedings of the ATS, February 15, 2008; 5(2): 144 - 153.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. C. Hlavac, P. G. Catcheside, A. Adams, D. J. Eckert, and R. D. McEvoy
The effects of hypoxia on load compensation during sustained incremental resistive loading in patients with obstructive sleep apnea
J Appl Physiol, July 1, 2007; 103(1): 234 - 239.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
P. W. Davenport, A. D. Martin, Y-L. Chou, and S. Alexander-Miller
Respiratory-related evoked potential elicited in tracheostomised lung transplant patients.
Eur. Respir. J., August 1, 2006; 28(2): 391 - 396.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
D. J. Eckert, P. G. Catcheside, R. McDonald, A. M. Adams, K. E. Webster, M. C. Hlavac, and R. D. McEvoy
Sustained Hypoxia Depresses Sensory Processing of Respiratory Resistive Loads
Am. J. Respir. Crit. Care Med., October 15, 2005; 172(8): 1047 - 1054.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. J. Tobin
Sleep-Disordered Breathing, Control of Breathing, Respiratory Muscles, and Pulmonary Function Testing in AJRCCM 2002
Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 306 - 318.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gora, J.
Right arrow Articles by Colrain, I. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gora, J.
Right arrow Articles by Colrain, I. M.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2002 American Thoracic Society